Literature DB >> 26037802

Absence epileptic activity changing effects of non-adenosine nucleoside inosine, guanosine and uridine in Wistar Albino Glaxo Rijswijk rats.

Z Kovács1, K A Kékesi2, Á Dobolyi3, R Lakatos4, G Juhász5.   

Abstract

Adenosine (Ado) and non-adenosine (non-Ado) nucleosides such as inosine (Ino), guanosine (Guo) and uridine (Urd) may have regionally different roles in the regulation of physiological and pathophysiological processes in the central nervous system (CNS) such as epilepsy. It was demonstrated previously that Ino and Guo decreased quinolinic acid (QA)-induced seizures and Urd reduced penicillin-, bicuculline- and pentylenetetrazole (PTZ)-induced seizures. It has also been demonstrated that Ino and Urd may exert their effects through GABAergic system by altering the function of GABA(A) type of gamma-aminobutyric acid receptors (GABAA receptors) whereas Guo decreases glutamate-induced excitability through glutamatergic system, which systems (GABAergic and glutamatergic) are involved in pathomechanisms of absence epilepsy. Thus, we hypothesized that Ino and Guo, similarly to the previously described effect of Urd, might also decrease absence epileptic activity. We investigated in the present study whether intraperitoneal (i.p.) application of Ino (500 and 1000mg/kg), Guo (20 and 50mg/kg), Urd (500 and 1000mg/kg), GABA(A) receptor agonist muscimol (1 and 3mg/kg), GABA(A) receptor antagonist bicuculline (2 and 4mg/kg), non-selective Ado receptor antagonist theophylline (5 and 10mg/kg) and non-competitive N-methyl-d-aspartate (NMDA) receptor antagonist (+)-5-methyl-10,11-dihydro-5H-dibenzo (a,d) cyclohepten-5,10-imine maleate (MK-801, 0.0625 and 0.1250mg/kg) alone and in combination have modulatory effects on absence epileptic activity in Wistar Albino Glaxo Rijswijk (WAG/Rij) rats. We found that Guo decreased the number of spike-wave discharges (SWDs) whereas Ino increased it dose-dependently. We strengthened that Urd can decrease absence epileptic activity. Our results suggest that Guo, Urd and their analogs could be potentially effective drugs for treatment of human absence epilepsy.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  WAG/Rij rats; absence epilepsy; guanosine; inosine; uridine

Mesh:

Substances:

Year:  2015        PMID: 26037802     DOI: 10.1016/j.neuroscience.2015.05.054

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

1.  Anti-aging effects of guanosine in glial cells.

Authors:  Débora Guerini Souza; Bruna Bellaver; Larissa Daniele Bobermin; Diogo Onofre Souza; André Quincozes-Santos
Journal:  Purinergic Signal       Date:  2016-09-01       Impact factor: 3.765

Review 2.  Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy.

Authors:  Karol Chojnowski; Mikolaj Opielka; Wojciech Nazar; Przemyslaw Kowianski; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

Review 3.  Guanosine and its role in neuropathologies.

Authors:  Luis E B Bettio; Joana Gil-Mohapel; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2016-03-22       Impact factor: 3.765

4.  Effects of intranasal guanosine administration on brain function in a rat model of ischemic stroke.

Authors:  Gabriel C Müller; Samanta O Loureiro; Letícia F Pettenuzzo; Roberto F Almeida; Evandro Y Ynumaru; Pedro A Guazzelli; Fabíola S Meyer; Mayara V Pasquetti; Marcelo Ganzella; Maria Elisa Calcagnotto; Diogo O Souza
Journal:  Purinergic Signal       Date:  2021-04-09       Impact factor: 3.765

5.  Exogenous Ketone Supplements Reduce Anxiety-Related Behavior in Sprague-Dawley and Wistar Albino Glaxo/Rijswijk Rats.

Authors:  Csilla Ari; Zsolt Kovács; Gabor Juhasz; Cem Murdun; Craig R Goldhagen; Andrew P Koutnik; Angela M Poff; Shannon L Kesl; Dominic P D'Agostino
Journal:  Front Mol Neurosci       Date:  2016-12-06       Impact factor: 5.639

6.  Adenosine A1 Receptor Antagonism Abolished the Anti-seizure Effects of Exogenous Ketone Supplementation in Wistar Albino Glaxo Rijswijk Rats.

Authors:  Zsolt Kovács; Dominic P D'Agostino; Arpád Dobolyi; Csilla Ari
Journal:  Front Mol Neurosci       Date:  2017-07-25       Impact factor: 5.639

7.  Zebrafish-based identification of the antiseizure nucleoside inosine from the marine diatom Skeletonema marinoi.

Authors:  Théo Brillatz; Chiara Lauritano; Maxime Jacmin; Supitcha Khamma; Laurence Marcourt; Davide Righi; Giovanna Romano; Francesco Esposito; Adrianna Ianora; Emerson F Queiroz; Jean-Luc Wolfender; Alexander D Crawford
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240

Review 8.  Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls.

Authors:  Gilles van Luijtelaar; Gerard van Oijen
Journal:  Front Pharmacol       Date:  2020-04-14       Impact factor: 5.810

Review 9.  Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders.

Authors:  Débora Lanznaster; Tharine Dal-Cim; Tetsadê C B Piermartiri; Carla I Tasca
Journal:  Aging Dis       Date:  2016-10-01       Impact factor: 6.745

Review 10.  Neuromodulatory Effects of Guanine-Based Purines in Health and Disease.

Authors:  Carla I Tasca; Débora Lanznaster; Karen A Oliveira; Victor Fernández-Dueñas; Francisco Ciruela
Journal:  Front Cell Neurosci       Date:  2018-10-23       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.